Novel Internet-Based Interventions to Reduce Sexual Risk Among Men Who Have Sex With Men
- Conditions
- HIV Infections
- Registration Number
- NCT00649701
- Lead Sponsor
- Public Health Solutions
- Brief Summary
The purpose of this study is to develop and test the efficacy of online HIV risk reduction interventions among men who have sex with men.
- Detailed Description
This is an Internet-based, five-branch randomized controlled intervention, enrolling 3,000 adult MSM. The five branches include 1) a control condition receiving no intervention content, 2) a standard text-based prevention webpage, 3) an 8 minute dramatic video addressing sexual risk reduction within the context of alcohol use, 4) a 5 minute documentary video addressing HIV disclosure, HIV testing, and condom use with the sub-context of drug use, and 5) both videos. After completing the baseline survey, eligible participants who consent to participate in the intervention will be randomly assigned to the control condition or one of the four intervention conditions. The control condition will not include the delivery of any intervention content. All participants (branches 1-5) will be asked to complete a brief post-intervention survey (to measure intentions). All intervention participants will be invited to complete a final 60-day follow-up survey.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Male
- Target Recruitment
- 3097
- Male;
- Age 18 and over;
- Ability to read and respond in English;
- Reside within the United States;
- Report oral or anal sex with any male (new partner or not) in the past 60 days AND report oral, anal or vaginal sex for the first time with any partner (male or female) in the past 60 days;
- Complete baseline survey
- Provide an email address;
- Women and transgender persons
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method HIV disclosure, HIV testing, and condom use 60 days
- Secondary Outcome Measures
Name Time Method drug and/or alcohol use before sex, and depressive and/or anxiety symptomatology (past 2 weeks) 60 days
Trial Locations
- Locations (1)
Public Health Solutions
🇺🇸New York, New York, United States
Public Health Solutions🇺🇸New York, New York, United States